Aldose Reductase (AR), the key enzyme of the polyol pathway catalyzes the reduction of glucose to sorbitol using nicotinamide adenine dinucleotide phosphate as an essential cofactor, has been demonstrated to play an important role in the pathogenesis of diabetic complications. Self Organizing Molecular Field Analysis (SOMFA), a novel three-dimensional quantitative structure activity relationship (3D-QSAR) method has been used in present case to study the correlation between the molecular properties and the aldose reductase inhibitory activities on a series of 5-arylidine-2, 4-thiazolidinedione. SOMFA calculations for both shape and electrostatic potentials were carried out. The master grid maps derived from the best model has been used to display the contribution of electrostatic potential and shape molecular field. The statistical results showed good cross-validated r(2)(CV), non cross-validated r(2), F-test set and significant predictive ability indicated by r(2)(pred). All analysis of SOMFA model may provide useful information in the design of new aldose reductase inhibitors with improved spectrum of activity for management of diabetic complications.

Download full-text PDF

Source
http://dx.doi.org/10.2174/157340610791208718DOI Listing

Publication Analysis

Top Keywords

aldose reductase
16
molecular field
12
series 5-arylidine-2
8
reductase inhibitors
8
field analysis
8
diabetic complications
8
analysis somfa
8
3d-qsar studies
4
studies series
4
5-arylidine-2 4-thiazolidinediones
4

Similar Publications

Decoding the SARS-CoV-2 infection process: Insights into origin, spread, and therapeutic approaches.

Microb Pathog

January 2025

Department of Bioengineering, Faculty of Engineering, Integral University, Lucknow, 226026, India. Electronic address:

Article Synopsis
  • Over 768 million confirmed COVID-19 cases and 6.9 million deaths have been recorded globally by July 17, 2023, highlighting the devastating impact of the pandemic.
  • SARS-CoV-2, the virus responsible for COVID-19, has a complex structure, including a large RNA genome and an envelope that aids in its infectivity, although its exact origin remains unclear.
  • The review discusses various topics related to COVID-19, including its origins, implications for health and the economy, and a controversial link between SARS-CoV-2 and the enzyme aldose reductase, which could have implications for treatment and understanding of the virus's pathogenesis.
View Article and Find Full Text PDF

Diabetes affects approximately 422 million people worldwide, leading to 1.5 million deaths annually and causing severe complications such as kidney failure, neuropathy, and cardiovascular disease. Aldose reductase (AR), a key enzyme in the polyol pathway, is an important therapeutic target for managing these complications.

View Article and Find Full Text PDF

Mechanisms and applications of bacterial luciferase and its auxiliary enzymes.

Arch Biochem Biophys

January 2025

Department of Biochemistry and Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand. Electronic address:

Bacterial luciferase (LuxAB) catalyzes the conversion of reduced flavin mononucleotide (FMNH⁻), oxygen, and a long-chain aldehyde to oxidized FMN, the corresponding acid and water with concomitant light emission. This bioluminescence reaction requires the reaction of a flavin reductase such as LuxG (in vivo partner of LuxAB) to supply FMNH⁻ for the LuxAB reaction. LuxAB is a well-known self-sufficient luciferase system because both aldehyde and FMNH⁻ substrates can be produced by the associated enzymes encoded by the genes in the lux operon, allowing the system to be auto-luminous.

View Article and Find Full Text PDF

Background: Diabetic myocardial disorder (DbMD, evidenced by abnormal echocardiography or cardiac biomarkers) is a form of stage B heart failure (SBHF) at high risk for progression to overt HF. SBHF is defined by abnormal LV morphology and function and/or abnormal cardiac biomarker concentrations.

Objective: To compare the evolution of four DbMD groups based on biomarkers alone, systolic and diastolic dysfunction alone, or their combination.

View Article and Find Full Text PDF

Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema.

Int J Mol Sci

January 2025

Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang 712082, China.

The Qinghai-Tibet Plateau, famously known as the "Roof of the World", has witnessed a surge in individuals traveling or working there. However, a considerable percentage of these individuals may suffer from acute mountain sickness (AMS), with high-altitude pulmonary edema (HAPE) being a severe and potentially life-threatening manifestation. HAPE disrupts the balance of intrapulmonary tissue fluid, resulting in severe lung function impairment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!